Uncertainties regarding NIH funding are causing negative impacts across the biotech industry, affecting sales, opportunities, and capital purchases in US academic labs.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Uncertainties regarding NIH funding are causing negative impacts across the biotech industry, affecting sales, opportunities, and capital purchases in US academic labs.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- NIH funding shifts are impacting research operations at Scripps Research.Sub-event
NIH funding issues are causing headwinds for the broader biotech sector and US academic labs.1 source
Keep exploring
The entities involved
-
National Institutes of Health
government organization in Shah Alam, Malaysia
Related events
- NIH cuts budgets and personnel, impacting funded research leading to FDA-approved treatments.
- NIH funding drops are impacting the sector of institutions in Massachusetts.
- The National Institutes of Health requires increased federal budget funding, with research demonstrating a potential $2.50 return on investment, discussed alongside U.S. Senator McCormick.
- A clinical study led by Dr. Swee Lay Thein is underway at the National Institutes of Health and is subject to oversight by the Food and Drug Administration.
- NIH data informs market need for a device that requires FDA clearance to achieve Medicare coverage.
Coverage
Newest first; wire copies grouped- GuruFocus.comQuantum-Si Inc (QSI) Q2 2025 Earnings Call Highlights: Navigating Challenges and Seizing New ... Release Date: August 05, 2025 For the complete transcript of the earnings call, please refer to the fu